Seeking Alpha
 

Aethlon Medical, Inc. (AEMD)

- OTCQB
  • Nov. 24, 2014, 1:43 PM
    • Nano cap Aethlon Medical (OTCQB:AEMD +31.8%) jumps on turnover of 22M. Shares are up almost seven-fold from mid-September and still haven't breached $0.70.
    • The company recently reported successful results with its Hemopurifier bio-filtration device on an Ebola patient.
    • Previously: Aethlon Medical up on successful Ebola treatment
    | 12 Comments
  • Nov. 17, 2014, 12:06 PM
    • Nano cap Aethlon Medical (OTCQB:AEMD +29.8%) jumps on massive turnover of 10M shares in response to its report of the successful treatment of a critically-ill Ebola patient in Germany with its Hemopurifier bio-filtration device. In a post-treatment analysis, the device captured 242M Ebola viruses. The patient is expected to make a full recovery.
    • The Hemopurifier targets the broad-spectrum elimination of viruses and immunosuppressive proteins from the blood.
    • The stock has more than tripled since mid-October when the first treatment with the Hemopurifier was reported.
    • Some of the members of the trading behavior-characterized Ebola Small Cap Index have completed their round trips. (HEB +1.2%)(TKMR +5.1%)(NLNK +2.5%)(NNVC -3.8%)(INO -8.5%)(OTCQB:GOVX)(SRPT -0.7%)(CMRX +4.4%)(PLX -1%)(NSPH -0.2%)(BCRX +0.7%)(LAKE +1.3%)(APT +0.2%)(VSR -0.7%)(SMED -2.7%)
    | 19 Comments
Visit Seeking Alpha's
AEMD vs. ETF Alternatives
Company Description
The Aethlon Medical mission is to create innovative devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. The Aethlon ADAPT system is an expansive technology platform that converges affinity drug agents and plasma membrane technology to... More